1. Market Research
  2. > Ferrer Internacional S.A. - Product Pipeline Review - 2013

Ferrer Internacional S.A. - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 39 pages

Ferrer Internacional S.A. - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “Ferrer Internacional S.A. - Product Pipeline Review - 2013” provides data on the Ferrer Internacional S.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Ferrer Internacional S.A.’s corporate website, SEC filings, investor presentations and featured press releases, both from Ferrer Internacional S.A. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Ferrer Internacional S.A. - Brief Ferrer Internacional S.A. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Ferrer Internacional S.A. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Ferrer Internacional S.A. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Ferrer Internacional S.A.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Ferrer Internacional S.A.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Ferrer Internacional S.A. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Ferrer Internacional S.A.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Ferrer Internacional S.A..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Ferrer Internacional S.A. and identify potential opportunities in those areas.

Table Of Contents

Ferrer Internacional S.A. - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Ferrer Internacional S.A. Snapshot 5
Ferrer Internacional S.A. Overview 5
Key Information 5
Key Facts 5
Ferrer Internacional S.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Ferrer Internacional S.A. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Ferrer Internacional S.A. - Pipeline Products Glance 11
Ferrer Internacional S.A. - Late Stage Pipeline 11
Filing rejected/Withdrawn Products/Combination Treatment Modalities 11
Phase III Products/Combination Treatment Modalities 12
Ferrer Internacional S.A. Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Ferrer Internacional S.A. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Ferrer Internacional S.A. - Drug Profiles 17
Antibacterial Program 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
arasertaconazole 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Drug Targeting Orexin 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
FIB-111 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
FIB-112 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
FIB-114 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
FIB-116 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
FIB-117 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
iguratimod 25
Product Description 25
Mechanism of Action 25
RandD Progress 25
lorediplon 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
Malaria Program 27
Product Description 27
Mechanism of Action 27
RandD Progress 27
ozenoxacin 28
Product Description 28
Mechanism of Action 28
RandD Progress 28
tesamorelin acetate 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
Ferrer Internacional S.A. - Pipeline Analysis 30
Ferrer Internacional S.A. - Pipeline Products by Therapeutic Class 30
Ferrer Internacional S.A. - Pipeline Products By Target 32
Ferrer Internacional S.A. - Pipeline Products by Route of Administration 33
Ferrer Internacional S.A. - Pipeline Products By Mechanism of Action 34
Ferrer Internacional S.A. - Recent Pipeline Updates 35
Ferrer Internacional S.A. - Dormant Projects 36
Ferrer Internacional S.A. - Locations And Subsidiaries 37
Head Office 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 39
Disclaimer 39

List of Tables

Ferrer Internacional S.A., Key Information 5
Ferrer Internacional S.A., Key Facts 5
Ferrer Internacional S.A. - Pipeline by Indication, 2013 7
Ferrer Internacional S.A. - Pipeline by Stage of Development, 2013 9
Ferrer Internacional S.A. - Monotherapy Products in Pipeline, 2013 10
Ferrer Internacional S.A. - Filing rejected/Withdrawn, 2013 11
Ferrer Internacional S.A. - Phase III, 2013 12
Ferrer Internacional S.A. - Phase II, 2013 13
Ferrer Internacional S.A. - Phase I, 2013 14
Ferrer Internacional S.A. - Preclinical, 2013 15
Ferrer Internacional S.A. - Discovery, 2013 16
Ferrer Internacional S.A. - Pipeline By Therapeutic Class, 2013 31
Ferrer Internacional S.A. - Pipeline By Target, 2013 32
Ferrer Internacional S.A. - Pipeline By Route of Administration, 2013 33
Ferrer Internacional S.A. - Pipeline Products By Mechanism of Action, 2013 34
Ferrer Internacional S.A. - Recent Pipeline Updates, 2013 35
Ferrer Internacional S.A. - Dormant Developmental Projects,2013 36

List of Figures

Ferrer Internacional S.A. - Pipeline by Indication, 2013 7
Ferrer Internacional S.A. - Pipeline by Stage of Development, 2013 9
Ferrer Internacional S.A. - Monotherapy Products in Pipeline, 2013 10
Ferrer Internacional S.A. - Pipeline By Therapeutic Class, 2013 30
Ferrer Internacional S.A. - Pipeline By Route of Administration, 2013 33
Ferrer Internacional S.A. - Pipeline Products By Mechanism of Action, 2013 34

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.